skip to Main Content
Data on Vaccination

Studies have revealed that influenza vaccination prevents medical visits and hospitalizations.3

  • During the 2015-2016 influenza season in the United States, the vaccine reduced outpatient influenza visits in adults by 53% for influenza B viruses and by 51% for influenza A viruses.3
  • The flu vaccine offered significant protection against influenza hospitalizations in the United States, including among adults over the age of 65. It reduced influenza hospitalizations by 50% among all adults and by 50% among adults >65 years of age (influenza A and B viruses).3
  • Flu vaccines have also been shown to be highly cost-effective in the prevention of acute myocardial infarction, particularly for high-risk people.4

AVAILABLE INFLUENZA VACCINES IN THE UNITED STATES, 2019-2020 INFLUENZA SEASON5

TRADE NAME

MANUFACTURER

AGE RANGE

Afluria® Quadrivalent

Seqirus

6 months and older

Fluad®

Seqirus

65 years and older

Fluad® Quadrivalent
(FDA approved; availability forthcoming)

Seqirus

65 years and older

Fluarix® Quadrivalent

GlaxoSmithKline

6 months and older

Flublok® Quadrivalent

Sanofi Pasteur

18 years and older

Flucelvax® Quadrivalent

Seqirus

4 years and older

FluLaval® Quadrivalent

ID Biomedical Corp. of Quebec, a subsidiary of GlaxoSmithKline

6 months and older

FluMist® Quadrivalent

AstraZeneca

2 through 49 years

Fluzone® High Dose

Sanofi Pasteur

65 years and older

Fluzone® High Dose Quadrivalent
(FDA approved; availability forthcoming)

Sanofi Pasteur

65 years and older

Fluzone® Quadrivalent

Sanofi Pasteur

6 months and older

HOW INFLUENZA VACCINES WORK

Flu vaccines cause antibodies to develop in the body about two weeks after vaccination. These antibodies provide protection against infection with the viruses that are in the vaccine.1

Seasonal flu vaccines protect against the influenza viruses that surveillance indicates are likely to be circulating in the upcoming flu season.1

Quadrivalent vaccines are made to protect against four flu viruses: two types of influenza A viruses (H1N1 and H3N2) and two types of influenza B viruses. Trivalent vaccines are made to protect against three flu viruses: the same influenza A viruses included in the quadrivalent vaccine and one influenza B virus.1

Preventing influenza helps reduce the potential loss of function in older adults. Sadly, approximately 14.6% of older adults hospitalized with influenza experience catastrophic disability, which is defined as a loss of independence of three or more basic activities of daily living (personal care and hygiene, mobility and being able to get in and out of bed or up from a chair or sofa, toileting, bathing and feeding).6, 7

The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recommends that all people 6 months of age and older receive an annual flu vaccine. 1

CLICK HERE for the latest ACIP recommendations on seasonal influenza vaccines

1. Key Facts About Seasonal Flu Vaccine. Centers for Disease Control and Prevention. https://www.cdc.gov/flu/protect/keyfacts.htm. 2. Flu Vaccination Coverage, United States, 2018-19 Influenza Season. https://www.cdc.gov/flu/fluvaxview/coverage-1819estimates.htm 3. Ferdinands J. Gaglani M. Martin E. et al. Prevention of Influenza Hospitalization Among Adults in the United States. 2015–2015: Results From the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). Journal of Infectious Diseases. Volume 220, Issue 8, 15 October 2019, Pages 1265- 1275. https://doi.org/10.1093/infdis/jiy723 4. MacIntyre CR, Mahimbo A, Moa AM, et al Influenza Vaccine as a Coronary Intervention for Prevention of Myocardial Infarction. Heart 2016;102:1953-1956. 5. U.S. Influenza Vaccine Products for the 2019-20 Season. Centers for Disease Control and Prevention https://www.cdc.gov/flu/professionals/vaccines.htm 6. Preventing Flu in Older Adults. Medscape. November 1, 2017. https://www.medscape.com/viewarticle/887671 7. Tan, L. How are Adult Immunizations Paid for in the United States? National Adult and Influenza Immunization Summit. 2018. http://www.allhealthpolicy.org/wp-content/uploads/2018/02/TAN.pdf


Back To Top